Related references
Note: Only part of the references are listed.Efflux Inhibition with Verapamil Potentiates Bedaquiline in Mycobacterium tuberculosis
Shashank Gupta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation
Roland Diel et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial
Aliaksandr Skrahin et al.
LANCET RESPIRATORY MEDICINE (2014)
Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice
Jacques H. Grosset et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor
Shashank Gupta et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Expression of M. tuberculosis-induced suppressor of cytokine signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates with differing clinical severity of tuberculosis
Kiran I. Masood et al.
BMC INFECTIOUS DISEASES (2013)
BCL-2 Inhibition: Stemming the Tide of Myeloid Malignancies
Leah J. Hogdal et al.
CELL STEM CELL (2013)
BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
Eleni D. Lagadinou et al.
CELL STEM CELL (2013)
Inflammasomes and host defenses against bacterial infections
Gregory I. Vladimer et al.
CURRENT OPINION IN MICROBIOLOGY (2013)
Autophagy as an immune effector against tuberculosis
Steven B. Bradfute et al.
CURRENT OPINION IN MICROBIOLOGY (2013)
TB: the Yin and Yang of lipid mediators
David M. Tobin et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Systems level immune response analysis and personalized medicine
Petter Brodin et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)
K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
Raul Munoz-Planillo et al.
IMMUNITY (2013)
Histone deacetylase inhibitors in the treatment for multiple myeloma
Teru Hideshima et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Clinical experience of using clofazimine to treat multidrug-resistant tuberculosis
Jung-Wan Yoo et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
Teesta Dey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Distinct Phases of Blood Gene Expression Pattern Through Tuberculosis Treatment Reflect Modulation of the Humoral Immune Response
Jacqueline M. Cliff et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis
Cristina Vilaplana et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Progress and challenges in childhood tuberculosis
Ben J. Marais et al.
LANCET INFECTIOUS DISEASES (2013)
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts
Ben J. Marais et al.
LANCET INFECTIOUS DISEASES (2013)
Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis
Julia A. Critchley et al.
LANCET INFECTIOUS DISEASES (2013)
Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1 beta
Bibhuti B. Mishra et al.
NATURE IMMUNOLOGY (2013)
Balancing tumor immunity and inflammatory pathology
Glenn Dranoff
NATURE MEDICINE (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Future of Antibiotics and Resistance
Brad Spellberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Autophagy in Human Health and Disease REPLY
Augustine M. K. Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Broad Profile of Co-Dominant Epitopes Shapes the Peripheral Mycobacterium tuberculosis Specific CD8+T-Cell Immune Response in South African Patients with Active Tuberculosis
Rebecca Axelsson-Robertson et al.
PLOS ONE (2013)
Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection
Claudia Manca et al.
PLOS ONE (2013)
Multiplicity of effectors of the cardioprotective agent, diazoxide
William A. Coetzee
PHARMACOLOGY & THERAPEUTICS (2013)
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
CD271+ Bone Marrow Mesenchymal Stem Cells May Provide a Niche for Dormant Mycobacterium tuberculosis
Bikul Das et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
BCG-specific IgG-secreting peripheral plasmablasts as a potential biomarker of active tuberculosis in HIV negative and HIV positive patients
Senait Ashenafi et al.
THORAX (2013)
Reactivation of latent HIV by histone deacetylase inhibitors
Kotaro Shirakawa et al.
TRENDS IN MICROBIOLOGY (2013)
Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay
Juan D. Guzman et al.
BMJ OPEN (2013)
Eliminating the latent HIV reservoir by reactivation strategies Advancing to clinical trials
Thomas A. Rasmussen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Vitamin D Induces Interleukin-1β Expression: Paracrine Macrophage Epithelial Signaling Controls M-tuberculosis Infection
Mark Verway et al.
PLOS PATHOGENS (2013)
Mycobacterium tuberculosis and the host cell inflannmasome: a complex relationship
Volker Briken et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
MECHANISMS OF DISEASE Autophagy in Human Health and Disease
Augustine M. K. Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Leprosy. An Update: Definition, Pathogenesis, Classification, Diagnosis, and Treatment
K. Eichelmann et al.
ACTAS DERMO-SIFILIOGRAFICAS (2013)
Corticosteroid-modulated Immune Activation in the Tuberculosis Immune Reconstitution Inflammatory Syndrome
Graeme Meintjes et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
David M. Tobin et al.
CELL (2012)
Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis
Anca Dorhoi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
Liang Shan et al.
IMMUNITY (2012)
Comparison of accessing online databases between physicians and nurses in Taiwan
Ya-Wen Chiu et al.
INFORMATICS FOR HEALTH & SOCIAL CARE (2012)
Tuberculosis and Tuberculosis/HIV/AIDS-Associated Mortality in Africa: The Urgent Need to Expand and Invest in Routine and Research Autopsies
Victor Mudenda et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Rational Development of Adjunct Immune-Based Therapies for Drug-Resistant Tuberculosis: Hypotheses and Experimental Designs
Alimuddin Zumla et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
The Immunological Footprint of Mycobacterium tuberculosis T-cell Epitope Recognition
Rebecca Axelsson-Robertson et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Adjunct Immunotherapies for Tuberculosis
Michael Uhlin et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Increased Levels of BAFF and APRIL Related to Human Active Pulmonary Tuberculosis
Kai Liu et al.
PLOS ONE (2012)
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
Manoj M. Lalu et al.
PLOS ONE (2012)
Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques
Philana Ling Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation
Eliseo F. Castillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
How host heterogeneity governs tuberculosis reinfection?
M. Gabriela M. Gomes et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Rituximab combination therapy in relapsing multiple sclerosis
Anne H. Cross et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Mycobacterium tuberculosis: success through dormancy
Martin Gengenbacher et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Apoptosis-Inducing Activity of Clofazimine in Macrophages
Yasuo Fukutomi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis
Ruth J. Napier et al.
CELL HOST & MICROBE (2011)
Critical role for NLRP3 in necrotic death triggered by Mycobacterium tuberculosis
Ka-Wing Wong et al.
CELLULAR MICROBIOLOGY (2011)
Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patients
M. Jacobsen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy
Stephen D. Lawn et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Increased (6 exon) interleukin-7 production after M. tuberculosis infection and soluble interleukin-7 receptor expression in lung tissue
L. Rane et al.
GENES AND IMMUNITY (2011)
Host-pathogen interactions Cell death and infection: A double-edged sword for host and pathogen survival
Hiroshi Ashida et al.
JOURNAL OF CELL BIOLOGY (2011)
Decreased IL-7 Signaling in T Cells From Patients With PTLD After Allogeneic HSCT
Hamdy Omar et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Outbreaks of Mycobacterium Tuberculosis MDR Strains Induce High IL-17 T-Cell Response in Patients With MDR Tuberculosis That Is Closely Associated With High Antigen Load
Juan I. Basile et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis
S. M. Behar et al.
MUCOSAL IMMUNOLOGY (2011)
Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease
Alexandre Harari et al.
NATURE MEDICINE (2011)
Regulation between survival, persistence, and elimination of intracellular mycobacteria: a nested equilibrium of delicate balances
Dhiraj Kumar et al.
MICROBES AND INFECTION (2011)
Identification of Probable Early-Onset Biomarkers for Tuberculosis Disease Progression
Jayne S. Sutherland et al.
PLOS ONE (2011)
Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study
Gro O. Eilertsen et al.
RHEUMATOLOGY (2011)
Immunological biomarkers of tuberculosis
Gerhard Walzl et al.
NATURE REVIEWS IMMUNOLOGY (2011)
The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans
David M. Tobin et al.
CELL (2010)
IL-17 and Th17 cells in tuberculosis
Egidio Torrado et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Increased IgG1, IFN-γ, TNF-α and IL-6 responses to Mycobacterium tuberculosis antigens in patients with Tuberculosis are lower after chemotherapy
Ana Marcia M. Mattos et al.
INTERNATIONAL IMMUNOLOGY (2010)
Immune responses to malignancies
Theresa L. Whiteside
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
The adaptor molecule CARD9 is essential for tuberculosis control
Anca Dorhoi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis
Andrea Cruz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Understanding Latent Tuberculosis: A Moving Target
Philana Ling Lin et al.
JOURNAL OF IMMUNOLOGY (2010)
Role of aspirin in tuberculous meningitis: A randomized open label placebo controlled trial
U. K. Misra et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Cytotoxic therapy for severe swine flu A/H1N1
Jan-Inge Henter et al.
LANCET (2010)
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Matthew P. R. Berry et al.
NATURE (2010)
Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines
Jun Fu et al.
NEURO-ONCOLOGY (2010)
Production of TNF-α, IL-12(p40) and IL-17 Can Discriminate between Active TB Disease and Latent Infection in a West African Cohort
Jayne S. Sutherland et al.
PLOS ONE (2010)
Humoral 'reactome' profiles using peptide microarray chips
Davide Valentini et al.
TRENDS IN IMMUNOLOGY (2010)
Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors
Nancie M. Archin et al.
AIDS (2009)
Sensing pathogens and danger signals by the inflammasome
Joao H. F. Pedra et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas-deficient MRL/lpr-/- murine model of autoimmune lymphoproliferative syndrome (ALPS)
Kennichi C. Dowdell et al.
EXPERIMENTAL HEMATOLOGY (2009)
Expression analysis and functional activity of interleukin-7 splice variants
N. K. Vudattu et al.
GENES AND IMMUNITY (2009)
Histone Deacetylase Inhibitors: Potential in Cancer Therapy
P. A. Marks et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus
Agnes Doreau et al.
NATURE IMMUNOLOGY (2009)
Pyroptosis: host cell death and inflammation
Tessa Bergsbaken et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Mycobacterium tuberculosis prevents inflammasome activation
Sharon S. Master et al.
CELL HOST & MICROBE (2008)
Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response
Joel Fleury Djoba Siawaya et al.
JOURNAL OF INFECTION (2008)
Pattern Recognition in Pulmonary Tuberculosis Defined by High Content Peptide Microarray Chip Analysis Representing 61 Proteins from M. tuberculosis
Simani Gaseitsiwe et al.
PLOS ONE (2008)
Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer
Nalini Kumar Vudattu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Changes in the kinetics of intracellular IFN-γ production in TB patients during treatment
Hanne Veenstra et al.
CLINICAL IMMUNOLOGY (2007)
Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo
Andrea J. Wolf et al.
JOURNAL OF IMMUNOLOGY (2007)
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
Shabaana A. Khader et al.
NATURE IMMUNOLOGY (2007)
Aspirin antagonism in isoniazid treatment of tuberculosis in mice
Sean T. Byrne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Dimethyl sulfoxide to vorinostat: Development of this histone deacetylase inhibitor as an anticancer drug
Paul A. Marks et al.
NATURE BIOTECHNOLOGY (2007)
Is Adipose Tissue a Place for Mycobacterium tuberculosis Persistence?
Olivier Neyrolles et al.
PLOS ONE (2006)
Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence
Vivek Rao et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia
GK Schleicher et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: A phase 2 clinical trial in Uganda
H Mayanja-Kizza et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Survival of virulent Mycobacterium tuberculosis involves preventing apoptosis induced by Bcl-2 upregulation and release resulting from necrosis in J774 macrophages
JL Zhang et al.
MICROBIOLOGY AND IMMUNOLOGY (2005)
The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy
MGM Gomes et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2004)
A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis
RS Wallis et al.
AIDS (2004)
Recurrent tuberculosis in the United States and Canada - Relapse or reinfection?
RM Jasmer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression
L Ylisastigui et al.
AIDS (2004)
Mechanisms of disease - Chronic myeloid leukemia - Advances in biology and new approaches to treatment
JM Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis
L Tsenova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers
P Sonnenberg et al.
LANCET (2001)
Reduced T-cell receptor CD3ζ-chain protein and sustained CD3ε expression at the site of mycobacterial infection
U Seitzer et al.
IMMUNOLOGY (2001)
Increased levels of circulating interleukin-18 in patients with advanced turberculosis
G Yamada et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice
MJ Maeurer et al.
INFECTION AND IMMUNITY (2000)
A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis
MS Glickman et al.
MOLECULAR CELL (2000)
Share Paper
